biotech marketing strategy

Posted in December 27, 2009 ¬ 6:44 pmh.BenComments Off

Teva acquired the rights to market oral laquinimod in the Nordic and Baltic Regions LUND, SWEDEN – (Marketwire – 02/08/10) – Site Web: www.tevapharm.com www.activebiotech.com/ Contact: Elana Holzman Teva Pharmaceutical Industries Ltd. 972 (3) 926-7554 Kevin Mannix Teva North America (215) 591-8912 Goran Forsberg Active Biotech AB +46 (0) 46-19 11 54 Teva acquires marketing rights for oral laquinimod in the Nordic and Baltic …
Genetically Modified Food Issues – Educational Video Part 2


Share Biotech News:
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • Identi.ca
  • LinkedIn
  • MySpace
  • Ping.fm
  • Twitter
Biological Engineering News, , , ,

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.